These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12427509)

  • 21. A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism. The THESEE Study Group. Tinzaparine ou Heparine Standard: Evaluations dans l'Embolie Pulmonaire.
    Simonneau G; Sors H; Charbonnier B; Page Y; Laaban JP; Azarian R; Laurent M; Hirsch JL; Ferrari E; Bosson JL; Mottier D; Beau B
    N Engl J Med; 1997 Sep; 337(10):663-9. PubMed ID: 9278462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low molecular weight heparin and bleeding in patients with chronic renal failure.
    Crowther M; Lim W
    Curr Opin Pulm Med; 2007 Sep; 13(5):409-13. PubMed ID: 17940486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management dilemma of cardiopulmonary bypass in patients with type II heparin-induced thrombocytopenia.
    Saad RA; Horn L; Mankad PS
    Br J Haematol; 2002 Dec; 119(3):880. PubMed ID: 12437678
    [No Abstract]   [Full Text] [Related]  

  • 24. Evidence-based emergency medicine/systematic review abstract. Use of low molecular weight heparins in patients with acute venous thromboembolism.
    Rowe BH; Lang ES
    Ann Emerg Med; 2002 May; 39(5):555-7. PubMed ID: 11973565
    [No Abstract]   [Full Text] [Related]  

  • 25. [Thrombocytosis: adverse effect of heparin treatment].
    Camou F; Viallard JF; Caubet O; Pellegrin JL
    Presse Med; 2006 Jan; 35(1 Pt 1):58-60. PubMed ID: 16462666
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The low molecular weight heparin, tinzaparin, in thrombosis and beyond.
    Mousa SA
    Cardiovasc Drug Rev; 2002; 20(3):199-216. PubMed ID: 12397367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An equivalence study of two low-molecular-weight heparins in the prevention and treatment of deep-vein thrombosis after total hip replacement.
    Planès A
    Semin Thromb Hemost; 2000; 26 Suppl 1():57-60. PubMed ID: 11011808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of serotonin reuptake inhibitors on hemostasis.
    Alderman CP; Seshadri P; Ben-Tovim DI
    Ann Pharmacother; 1996 Nov; 30(11):1232-4. PubMed ID: 8913401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tinzaparin sodium: a review of its use in the prevention and treatment of deep vein thrombosis and pulmonary embolism, and in the prevention of clotting in the extracorporeal circuit during haemodialysis.
    Hoy SM; Scott LJ; Plosker GL
    Drugs; 2010 Jul; 70(10):1319-47. PubMed ID: 20568836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serotonin reuptake inhibitor antidepressants and abnormal bleeding: a review for clinicians and a reconsideration of mechanisms.
    Andrade C; Sandarsh S; Chethan KB; Nagesh KS
    J Clin Psychiatry; 2010 Dec; 71(12):1565-75. PubMed ID: 21190637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SSRI-induced bleeding: two case reports.
    Vandel P; Vandel S; Kantelip JP
    Therapie; 2001; 56(4):445-7. PubMed ID: 11677872
    [No Abstract]   [Full Text] [Related]  

  • 32. Diffuse alopecia in a hemodialysis patient caused by a low-molecular-weight heparin, tinzaparin.
    Sarris E; Tsele E; Bagiatoudi G; Salpigidis K; Stavrianaki D; Kaklamanis L; Siakotos M
    Am J Kidney Dis; 2003 May; 41(5):E15. PubMed ID: 12778433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tinzaparin.
    Wong NN
    Heart Dis; 2002; 4(5):331-40. PubMed ID: 12350245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Thromboembolism].
    Fitzmaurice DA; Hobbs FD
    Vasa; 2001 May; 30(2):141-5. PubMed ID: 11417288
    [No Abstract]   [Full Text] [Related]  

  • 35. Self-managed long-term low-molecular-weight heparin therapy: the balance of benefits and harms.
    Hull RD; Pineo GF; Brant RF; Mah AF; Burke N; Dear R; Wong T; Cook R; Solymoss S; Poon MC; Raskob G;
    Am J Med; 2007 Jan; 120(1):72-82. PubMed ID: 17208082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Severe hemorrhagic complications during treatment with low molecular weight heparin. Apropos of 2 cases].
    Grateau G; Chauvenet L; Oudard S; Bachmeyer C; Capron L; Horellou MH; Samama MM
    Rev Med Interne; 1997; 18(5):411-5. PubMed ID: 9183451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dabigatran: new drug. Continue to use heparin, a better-known option.
    Prescrire Int; 2009 Jun; 18(101):97-9. PubMed ID: 19637411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Patient with antithrombotic medication. Which do bleedings or preoperative?].
    Stiefelhagen P
    Laryngorhinootologie; 2006 Jan; 85(1):50-60; quiz 61-5. PubMed ID: 16444657
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low molecular weight heparins: practical considerations.
    Kessler CM
    Semin Hematol; 1997 Oct; 34(4 Suppl 4):35-42. PubMed ID: 9399408
    [No Abstract]   [Full Text] [Related]  

  • 40. New anticoagulants in ischemic heart disease.
    Verheugt FW
    Presse Med; 2005 Oct; 34(18):1325-9. PubMed ID: 16269997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.